Course Code:   CPE21MC-AUD

Course Information

This series is rapidly evolving and more sessions will be added in the coming weeks!

Auditory Neuropathy Spectrum Disorder – putting the ‘spectrum’ into perspective.  Thursday 29 April, 12-1pm AEST.

Presented by Dr Kirsty Gardner-Berry

Whilst auditory neuropathy spectrum disorder (ANSD) is known to result in a wide range of outcomes with both hearing aids and cochlear implants it’s not always easy to decipher from the literature which of the key elements are at play and how to best counsel clients and families about the most appropriate management pathway for their specific presentation.  In this webinar a combination of age-of-onset and diagnostic assessment tools will be presented to help clinicians categorize different ANSD sub-groups, explain the variation in outcomes seen, and guide the clinical management pathway moving forward.

Shifting the Goal Posts. Hearing loss & Cochlear implantation in the Australian Landscape. Thursday May 20, 12-1pm AEST.

Presented by Emma Ramsay

Australian Professor Graeme Clark AC was inspired by his deaf father to help deaf people hear. The ground breaking research he led in Australia began in the late 1960s, when almost all auditory neurophysiologists believed that providing useful hearing through electrical stimulation would be impossible.

When cochlear implants were first commercialised most potential candidates and health care professionals hoped the device would be an aid to lip reading. Forty years later the goal posts have shifted considerably and expectations include the ability to swim wearing the device, cell phone connectivity, hearing in noise and much, much more. Cochlear has continued with global clinical research and technology development programs, integrating new findings into products with enhanced performance and usability to meet these growing and ever changing expectations.

In this session you will hear Cochlear Australia New Zealand’s Clinical Director Emma Ramsay , discuss the improvements the Cochlear implant industry has seen over the last 20 years,  how the Australian landscape has changed and improvements still needed and learn about ways  Cochlear’s technology can maximise hearing and lifestyle outcomes.

These two events have been endorsed for 1 CPD point in category 1.2 by Audiology Australia.


APST logo


This event addresses the following Standards from the Australian Professional Standards for Teachers: 1.1.2, 1.2.2, 1.3.2, 1.4.2, 1.5.2, 1.6.2, 2.6.2, 3.2.2, 3.3.2, 3.4.2, 3.6.2, 4.1.2, 4.4.2, 4.5.2, 5.1.2, 5.2.2, 5.3.2, 5.4.2, 6.2.2, 6.2.6, 6.3.2, 6.4.2, 7.4.2. It fits within the Priority Area of Children/ Student with Disabilities. These events are research and evidence based.


  • Kirsty Gardner-Berry
    Dr Kirsty Gardner-Berry BSc. M.Aud. MASA (ccp) PhD   Dr. Kirsty Gardner-Berry is a diagnostic audiologist at the Sydney Cochlear Implant Centre (SCIC), and consultant audiologist in newborn hearing screening at Scanmedics.  Kirsty completed her Bachelor of Science and post-graduate diploma in Audiology at the University of Melbourne; her Masters in audiology at Macquarie University; and Doctor of Philosophy at the University of Sydney.  Kirsty has been working as an audiologist for 25 years.  Her main areas of interest are in the early identification of hearing loss, and the use of electrophysiological testing techniques to assess and manage hearing disorders.   Kirsty’s PhD was on auditory neuropathy spectrum disorder (ANSD) in infants, and she has studied the use of electrocochleography (ECochG), auditory brainstem response, cochlear implant evoked electrical auditory brainstem response (ImpEABR), and cortical auditory evoked potentials (CAEPs) in this patient group.  Her current clinical and research work includes the use of cortical auditory evoked potentials to assess auditory function and promote optimal hearing aid following newborn hearing screening.  
  • Emma Ramsay

    Over her 20+ year career, Emma Ramsay worked in Australia and internationally as a Speech Pathologist and Audiologist.  Emma is a member of Cochlear Limited’s Australian leadership team, holding the role of Clinical Director for Australia and New Zealand.  In this role, she is responsible for clinical leadership and delivering services to 17,000+ recipients.

    Emma has a Bachelor of Applied Science in Speech Pathology and a Masters in Clinical Audiology.  Emma has a Certificate IV in Training and Assessment and participated in a Leading Innovative Change Leadership program through UC Berkeley Center for Executive Education.  To supplement her clinical knowledge, Emma has taken select leadership courses, particularly in the field of Customer Service and Communications. 

    Emma began her career at Sydney Cochlear Implant Centre (SCIC). This was followed by an appointment with United Kingdom's renowned Great Ormond Street Hospital for Children, where Emma held the position of Chief Audiologist. Emma joined Cochlear Ltd in 2008, where she has held positions in the Asia Pacific clinical education team and marketing team. Emma has extensively travelled Asia Pacific supporting, presenting to and training hearing health care professionals on clinical best practice. Emma was appointed as a Director on the board of Audiology Australia in 2019.





These are accessible and convenient to be viewed at any time. These sessions are presented by local staff at RIDBC, as well as national and international experts. If a course or webinar is accredited through either The NSW Education Standards Authority (NESA), formerly known as BOSTES, AG Bell or Audiology Australia, it will be indicated within the description of the webinar. If you are unsure and would like further information regarding accreditation, please contact Carla Silveira, Events and Administration Coordinator (


Details Price Qty
Full Registration (All 6 sessions)show details + $200.00 (AUD)  
Session 1: Auditory Neuropathy Spectrum Disordershow details + $50.00 (AUD)  
Session 2: Shifting the Goal Postsshow details + $50.00 (AUD)  

Registrations can only be confirmed
with payment by:
VISA and Mastercard Credit Cards